Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin (Q35533543)

8 August 2017

title

Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin (English)

1 reference

8 August 2017

1 reference

1 reference

Torres A

1 reference

8 August 2017

Bauer TT

1 reference

8 August 2017

León-Gil C

1 reference

8 August 2017

Castillo F

1 reference

8 August 2017

Alvarez-Lerma F

1 reference

8 August 2017

Martínez-Pellús A

1 reference

8 August 2017

Leal-Noval SR

1 reference

8 August 2017

Nadal P

1 reference

8 August 2017

Palomar M

1 reference

8 August 2017

Blanquer J

1 reference

8 August 2017

Ros F

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

8 August 2017

1 reference

8 August 2017

1 reference

8 August 2017

1 reference

8 August 2017

page(s)

1033-1039

1 reference

Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745648

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745648

Monotherapy is appropriate for nosocomial pneumonia in the intensive care unit.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745648

Comparative study of imipenem in severe infections

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745648

Comparative clinical evaluation of imipenem/cilastatin vs. cefotaxime in treatment of severe bacterial infections.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745648

Prospective randomized comparison of imipenem/cilastatin and cefotaxime for treatment of lung, soft tissue, and renal infections

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745648

Pneumonia treated with imipenem/cilastatin.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745648

Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infections

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745648

Imipenem/cilastatin in the treatment of severe nosocomial pneumonia.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745648

Ciprofloxacin in the treatment of pneumonia

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745648

Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradication.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745648

Preventing nosocomial pneumonia: state of the art and perspectives for the 1990s

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745648

Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745648

Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745648

Treatment of pneumonia with imipenem/cilastatin

26 September 2018

1 reference

12 December 2020

Clinical outcome of nosocomial pneumonia following imipenem/cilastatin therapy

1 reference

12 December 2020

Combination of cisplatin plus fluoropyrimidine chemotherapy effective against liver metastases from carcinoma of the anal canal

1 reference

12 December 2020

Sequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory tract infections

1 reference

12 December 2020

Comparative clinical trial of ceftazidime and imipenem/cilastatin in patients with severe nosocomial pneumonias and septicaemias

1 reference

12 December 2020

Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients

1 reference

12 December 2020

Intravenous ciprofloxacin versus ceftazidime for treatment of nosocomial pneumonia and urinary tract infection

1 reference

12 December 2020

Quantitative cultures of endotracheal aspirates for the diagnosis of ventilator-associated pneumonia

1 reference

12 December 2020

Treatment of pneumonia in mechanically ventilated trauma patients. Results of a prospective trial

1 reference

12 December 2020

10.1136/THORAX.55.12.1033

Identifiers

DOI

1 reference

8 August 2017

1 reference

8 August 2017

1 reference